HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metastatic extraskeletal myxoid chondrosarcoma. Successful therapy with interferon alfa-2b.

Abstract
A patient with pulmonary metastatic extraskeletal myxoid chondrosarcoma (EMC), of unknown cause, responded dramatically to 16 months of therapy with interferon alfa-2b. This is the first report of a significant response of a patient with EMC to this novel treatment approach.
AuthorsM Rubinger, I H Plenderleith, M Lertzman, A J Worth
JournalChest (Chest) Vol. 108 Issue 1 Pg. 281-2 (Jul 1995) ISSN: 0012-3692 [Print] United States
PMID7606973 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
Topics
  • Chondrosarcoma (diagnostic imaging, drug therapy, secondary)
  • Humans
  • Interferon alpha-2
  • Interferon-alpha (therapeutic use)
  • Lung Neoplasms (diagnostic imaging, drug therapy, secondary)
  • Male
  • Middle Aged
  • Neoplasms, Unknown Primary
  • Radiography
  • Recombinant Proteins
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: